Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC

INTRODUCTION: Co-occurring mutations in KRAS-mutant NSCLC are associated with discrete biological properties and modulate therapeutic susceptibilities. As G12D-specific inhibitors are expected to enter the clinic, we sought to investigate the characteristics and outcomes of patients with KRAS G12D-m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Alissa J., Muzikansky, Alona, Lennerz, Jochen, Narinesingh, Farhaana, Mino-Kenudson, Mari, Hung, Yin P., Piotrowska, Zofia, Dagogo-Jack, Ibiayi, Sequist, Lecia V., Gainor, Justin F., Lin, Jessica J., Heist, Rebecca S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471201/
https://www.ncbi.nlm.nih.gov/pubmed/36118132
http://dx.doi.org/10.1016/j.jtocrr.2022.100390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471201/
https://www.ncbi.nlm.nih.gov/pubmed/36118132
http://dx.doi.org/10.1016/j.jtocrr.2022.100390

Ejemplares similares